Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms

References

• Zhang PP, Li LL, Han X, Li QW, Zhang XH, Liu JJ, Wang Y. Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice. Acta Pharmacol Sin. 2020;41(5):678–20. doi:10.1038/s41401-019-0330-9.
   PubMed Web of Science ®Google Scholar
• Oniszczuk A, Oniszczuk T, Gancarz M, Szymanska J. Role of gut microbiota, probiotics and prebiotics in the cardiovascular diseases. Molecules. 2021;26(4):1172. doi:10.3390/molecules26041172.
   PubMed Web of Science ®Google Scholar
• Oh YJ, Pau VC, Steppan J, Sikka G, Bead VR, Nyhan D, Levine BD, Berkowitz DE, Santhanam L. Role of tissue transglutaminase in age-associated ventricular stiffness. Amino Acids. 2017;49(3):695–704. doi:10.1007/s00726-016-2295-z.
   PubMed Web of Science ®Google Scholar
• Wenzel P, Schuhmacher S, Kienhofer J, Muller J, Hortmann M, Oelze M, Schulz E, Treiber N, Kawamoto T, Scharffetter-Kochanek K, et al. Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc Res. 2008;80(2):280–289. doi:10.1093/cvr/cvn182.
   PubMed Web of Science ®Google Scholar
• Didion SP, Kinzenbaw DA, Schrader LI, Faraci FM. Heterozygous CuZn superoxide dismutase deficiency produces a vascular phenotype with aging. Hypertension. 2006;48(6):1072–1079. doi:10.1161/01.HYP.0000247302.20559.3a.
   PubMed Web of Science ®Google Scholar
• Babcock MC, DuBose LE, Witten TL, Stauffer BL, Hildreth KL, Schwartz RS, Kohrt WM, Moreau KL. Oxidative stress and inflammation are associated with age-related endothelial dysfunction in men with Low Testosterone. J Clin Endocrinol Metab. 2022;107(2):e500–e514. doi:10.1210/clinem/dgab715.
   PubMed Web of Science ®Google Scholar
• Chen SY, Wang TY, Zhao C, Wang HJ. Oxidative stress bridges the gut microbiota and the occurrence of frailty syndrome. World J Gastroenterol. 2022;28(38):5547–5556. doi:10.3748/wjg.v28.i38.5547.
   PubMed Web of Science ®Google Scholar
• Cha B, Lim JW, Kim KH, Kim H. d15-deoxy-Δ12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells. J Physiol Pharmacol. 2011;62:167–174.
   PubMed Web of Science ®Google Scholar
• Choi JH, Cho SO, Kim H. α-Lipoic acid inhibits expression of IL-8 by suppressing activation of MAPK, Jak/Stat, and NF-κB in H. pylori-infected gastric epithelial AGS cells. Yonsei Med J. 2016;57(1):260–264. doi:10.3349/ymj.2016.57.1.260.
   PubMed Web of Science ®Google Scholar
• Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. Excli J. 2021;20:301–319. doi:10.17179/excli2020-3239.
   PubMed Web of Science ®Google Scholar
• Zhou S, Xue J, Shan J, Hong Y, Zhu W, Nie Z, Zhang Y, Ji N, Luo X, Zhang T, et al. Gut-flora-dependent metabolite trimethylamine-N-Oxide promotes atherosclerosis-associated inflammation responses by indirect ROS stimulation and signaling involving AMPK and SIRT1. Nutrients. 2022;14(16):3338. doi:10.3390/nu14163338.
   PubMed Web of Science ®Google Scholar
• Choy KW, Lau YS, Murugan D, Vanhoutte PM, Mustafa MR. Paeonol attenuates LPS-Induced endothelial dysfunction and apoptosis by inhibiting BMP4 and TLR4 signaling simultaneously but independently. J Pharmacol Exp Ther. 2018;364(3):420–432. doi:10.1124/jpet.117.245217.
   PubMed Web of Science ®Google Scholar
• West SA. Medical education and the role of computers–as seen through the eyes of a medical student. J Med Syst. 1989;13(5):237–241. doi:10.1007/BF00996457.
   PubMedGoogle Scholar
• Dubois-Deruy E, Peugnet V, Turkieh A, Pinet F. Oxidative Stress in Cardiovascular Diseases. Antioxid (Basel). 2020;9(9):9. doi:10.3390/antiox9090864.
   Google Scholar
• Moris D, Spartalis M, Tzatzaki E, Spartalis E, Karachaliou GS, Triantafyllis AS, Karaolanis GI, Tsilimigras DI, Theocharis S. The role of reactive oxygen species in myocardial redox signaling and regulation. Ann Transl Med. 2017;5(16):324. doi:10.21037/atm.2017.06.17.
   PubMed Web of Science ®Google Scholar
• Feng W, Xu X, Zhao G, Zhao J, Dong R, Ma B, Zhang Y, Long G, Wang DW, Tu L, et al. Increased age-related cardiac dysfunction in bradykinin B2 receptor–deficient mice. J Gerontol A Biol Sci Med Sci. 2016;71(2):178–187. doi:10.1093/gerona/glu210.
   PubMed Web of Science ®Google Scholar
• Dai DF, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ, Gollahon K, Martin GM, Loeb LA, Ladiges WC, et al. Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation. 2009;119(21):2789–2797. doi:10.1161/CIRCULATIONAHA.108.822403.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen P, Cao Q, Wang W, Chang X. Traditional Chinese medicine ginseng dingzhi decoction ameliorates myocardial fibrosis and high glucose-induced cardiomyocyte injury by regulating intestinal flora and mitochondrial dysfunction. Oxid Med Cell Longev. 2022;2022:1–33. doi:10.1155/2022/9205908.
   Web of Science ®Google Scholar
• Yoo W, Zieba JK, Foegeding NJ, Torres TP, Shelton CD, Shealy NG, Byndloss AJ, Cevallos SA, Gertz E, Tiffany CR, et al. High-fat diet–induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Sci. 2021;373(6556):813–818. doi:10.1126/science.aba3683.
   PubMed Web of Science ®Google Scholar
• Zhao M, Wei H, Li C, Zhan R, Liu C, Gao J, Yi Y, Cui X, Shan W, Ji L, et al. Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy. Nat Commun. 2022;13(1):1757. doi:10.1038/s41467-022-29060-7.
   PubMed Web of Science ®Google Scholar
• Dutta D, Calvani R, Bernabei R, Leeuwenburgh C, Marzetti E, Sinclair D, North B. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res. 2012;110(8):1125–1138. doi:10.1161/CIRCRESAHA.111.246108.
   PubMed Web of Science ®Google Scholar
• Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A. 1997;94(2):514–519. doi:10.1073/pnas.94.2.514.
   PubMed Web of Science ®Google Scholar
• Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly-Y M, Gidlöf S, Oldfors A, Wibom R, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004;429(6990):417–423. doi:10.1038/nature02517.
   PubMed Web of Science ®Google Scholar
• Dai DF, Chen T, Wanagat J, Laflamme M, Marcinek DJ, Emond MJ, Ngo CP, Prolla TA, Rabinovitch PS. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell. 2010;9(4):536–544. doi:10.1111/j.1474-9726.2010.00581.x.
   PubMed Web of Science ®Google Scholar
• Wang J, Li S, Wang J, Wu F, Chen Y, Zhang H, Guo Y, Lin Y, Li L, Yu X, et al. Spermidine alleviates cardiac aging by improving mitochondrial biogenesis and function. Aging (Albany NY). 2020;12(1):650–671. doi:10.18632/aging.102647.
   PubMedGoogle Scholar
• Wu NN, Zhang Y, Ren J. Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging. Oxid Med Cell Longev. 2019;2019:1–15. doi:10.1155/2019/9825061.
   Web of Science ®Google Scholar
• Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9–14. doi:10.1038/nrm3028.
   PubMed Web of Science ®Google Scholar
• Doblado L, Lueck C, Rey C, Samhan-Arias AK, Prieto I, Stacchiotti A, Monsalve M. Mitophagy in human diseases. Int J Mol Sci. 2021;22(8):3903. doi:10.3390/ijms22083903.
   PubMed Web of Science ®Google Scholar
• Omar NN, Mosbah RA, Sarawi WS, Rashed MM, Badr AM. Rifaximin protects against malathion-induced rat testicular toxicity: a possible clue on modulating gut microbiome and inhibition of oxidative stress by Mitophagy. Molecules. 2022;27(13):4069. doi:10.3390/molecules27134069.
   PubMed Web of Science ®Google Scholar
• Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA. Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol. 2018;9:586. doi:10.3389/fimmu.2018.00586.
   PubMed Web of Science ®Google Scholar
• Chung HY, Kim DH, Lee EK, Chung KW, Chung S, Lee B, Seo AY, Chung JH, Jung YS, Im E, et al. Redefining chronic inflammation in aging and age-related diseases: proposal of the senoinflammation concept. Aging Dis. 2019;10(2):367–382. doi:10.14336/AD.2018.0324.
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–522. doi:10.1038/s41569-018-0064-2.
   PubMed Web of Science ®Google Scholar
• Cao S, Zhang Q, Wang C, Wu H, Jiao L, Hong Q, Hu C. LPS challenge increased intestinal permeability, disrupted mitochondrial function and triggered mitophagy of piglets. Innate Immun. 2018;24(4):221–230. doi:10.1177/1753425918769372.
   PubMed Web of Science ®Google Scholar
• Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR-4 and CD14. Am J Pathol. 2013;182(2):375–387. doi:10.1016/j.ajpath.2012.10.014.
   PubMed Web of Science ®Google Scholar
• Al BZ, Nitert MD, Mousa A, Naderpoor N. The Gut Microbiota and Inflammation: An Overview. Int J Environ Res Public Health. 2020;17(20):7618. doi:10.3390/ijerph17207618.
   PubMed Web of Science ®Google Scholar
• Jia G, Aroor AR, Jia C, Sowers JR. Endothelial cell senescence in aging-related vascular dysfunction. Biochim Biophys Acta Mol Basis Dis. 2019;1865(7):1802–1809. doi:10.1016/j.bbadis.2018.08.008.
   PubMed Web of Science ®Google Scholar
• Barbe-Tuana F, Funchal G, Schmitz C, Maurmann RM, Bauer ME. The interplay between immunosenescence and age-related diseases. Semin Immunopathol. 2020;42(5):545–557. doi:10.1007/s00281-020-00806-z.
   PubMed Web of Science ®Google Scholar
• Donato AJ, Eskurza I, Silver AE, Levy AS, Pierce GL, Gates PE, Seals DR. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-κB. Circ Res. 2007;100(11):1659–1666. doi:10.1161/01.RES.0000269183.13937.e8.
   PubMed Web of Science ®Google Scholar
• Donato AJ, Black AD, Jablonski KL, Gano LB, Seals DR. Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 2008;7(6):805–812. doi:10.1111/j.1474-9726.2008.00438.x.
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z, Smith K, Csiszar A. Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007;293(1):H37–H47. doi:10.1152/ajpheart.01346.2006.
   PubMed Web of Science ®Google Scholar
• Donato AJ, Pierce GL, Lesniewski LA, Seals DR. Role of NFκB in age-related vascular endothelial dysfunction in humans. Aging (Albany NY). 2009;1(8):678–680. doi:10.18632/aging.100080.
   PubMedGoogle Scholar
• Sun Y, Li M, Zhao D, Li X, Yang C, Wang X. Lysosome activity is modulated by multiple longevity pathways and is important for lifespan extension in C. elegans. Elife. 2020;9:e55745. doi:10.7554/eLife.55745.
   PubMed Web of Science ®Google Scholar
• Hughes AL, Gottschling DE. An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast. Nature. 2012;492(7428):261–265. doi:10.1038/nature11654.
   PubMed Web of Science ®Google Scholar
• Ryu JY, Choi HM, Yang HI, Kim KS. Dysregulated autophagy mediates Sarcopenic obesity and its complications via AMPK and PGC1α signaling pathways: potential involvement of gut dysbiosis as a pathological link. Int J Mol Sci. 2020;21(18):6887. doi:10.3390/ijms21186887.
   PubMed Web of Science ®Google Scholar
• Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger MK, Bultman S. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13(5):517–526. doi:10.1016/j.cmet.2011.02.018.
   PubMed Web of Science ®Google Scholar
• Engevik MA, Luk B, Chang-Graham AL, Hall A, Herrmann B, Ruan W, Endres BT, Shi Z, Garey KW, Hyser JM, et al. Bifidobacterium dentium fortifies the intestinal mucus layer via autophagy and calcium signaling pathways. Mbio. 2019;10(3):e01087–19. doi:10.1128/mBio.01087-19.
   PubMed Web of Science ®Google Scholar
• Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nat Med. 2016;22(12):1428–1438. doi:10.1038/nm.4222.
   PubMed Web of Science ®Google Scholar
• He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of bcl-2–Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes. 2013;62(4):1270–1281. doi:10.2337/db12-0533.
   PubMed Web of Science ®Google Scholar
• Wang L, Ma H, Huang P, Xie Y, Near D, Wang H, Xu J, Yang Y, Xu Y, Garbutt T, et al. Down-regulation of Beclin1 promotes direct cardiac reprogramming. Sci Transl Med. 2020;12(566):12. doi:10.1126/scitranslmed.aay7856.
   Web of Science ®Google Scholar
• Fernandez AF, Sebti S, Wei Y, Zou Z, Shi M, McMillan KL, He C, Ting T, Liu Y, Chiang W-C, et al. Disruption of the beclin 1/Bcl-2 autophagy regulatory complex promotes longevity in mice. Nature. 2018;558(7708):136–140. doi:10.1038/s41586-018-0162-7.
   PubMed Web of Science ®Google Scholar
• Woodall BP, Gustafsson AB. Autophagy—A key pathway for cardiac health and longevity. Acta Physiol (Oxf). 2018;223(4):e13074. doi:10.1111/apha.13074.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang D, Wiersma M, Brundel B. Role of autophagy in Proteostasis: friend and foe in cardiac diseases. Cells. 2018;7(12):279. doi:10.3390/cells7120279.
   PubMed Web of Science ®Google Scholar
• Robertson RC, Manges AR, Finlay BB, Prendergast AJ. The human microbiome and child growth – first 1000 days and beyond. Trends Microbiol. 2019;27(2):131–147. doi:10.1016/j.tim.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Anwar H, Iftikhar A, Muzaffar H, Almatroudi A, Allemailem KS, Navaid S, Saleem S, Khurshid M. Biodiversity of gut microbiota: impact of various Host and environmental factors. Biomed Res Int. 2021;2021:1–9. doi:10.1155/2021/5575245.
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010;107(26):11971–11975. doi:10.1073/pnas.1002601107.
   PubMed Web of Science ®Google Scholar
• Roswall J, Olsson LM, Kovatcheva-Datchary P, Nilsson S, Tremaroli V, Simon MC, Kiilerich P, Akrami R, Krämer M, Uhlén M, et al. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host & Microbe. 2021;29(5):765–776.e3. doi:10.1016/j.chom.2021.02.021.
   PubMed Web of Science ®Google Scholar
• Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interactions. Sci. 2012;336(6086):1262–1267. doi:10.1126/science.1223813.
   PubMed Web of Science ®Google Scholar
• Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkïla J, Monti D, Satokari R, Franceschi C, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE. 2010;5(5):e10667. doi:10.1371/journal.pone.0010667.
   PubMed Web of Science ®Google Scholar
• Salazar N, Arboleya S, Fernandez-Navarro T, de Los CG, Gonzalez S, Gueimonde M. Age-associated changes in gut microbiota and dietary components related with the immune system in Adulthood and old age: a cross-sectional study. Nutrients. 2019;11(8):11. doi:10.3390/nu11081765.
   Web of Science ®Google Scholar
• Rampelli S, Candela M, Turroni S, Biagi E, Collino S, Franceschi C, O’Toole PW, Brigidi P. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging (Albany NY). 2013;5(12):902–912. doi:10.18632/aging.100623.
   PubMedGoogle Scholar
• Fransen F, van Beek AA, Borghuis T, Aidy SE, Hugenholtz F, van der Gaast-de JC, Savelkoul HFJ, De Jonge MI, Boekschoten MV, Smidt H, et al. Aged gut microbiota contributes to systemical inflammaging after transfer to germ-free mice. Front Immunol. 2017;8:1385. doi:10.3389/fimmu.2017.01385.
   PubMed Web of Science ®Google Scholar
• DeJong EN, Surette MG, Bowdish D. The gut microbiota and unhealthy aging: disentangling cause from consequence. Cell Host & Microbe. 2020;28(2):180–189. doi:10.1016/j.chom.2020.07.013.
   PubMed Web of Science ®Google Scholar
• Rath S, Rox K, Kleine BS, Schminke U, Dorr M, Mayerle J, Frost F, Lerch MM, Karch A, Brönstrup M, et al. Higher trimethylamine-N-Oxide plasma levels with increasing age are mediated by diet and trimethylamine-forming bacteria. mSystems. 2021;6(5):e94521. doi:10.1128/mSystems.00945-21.
   Web of Science ®Google Scholar
• Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol. 2014;39(3):230–237. doi:10.1159/000360010.
   PubMed Web of Science ®Google Scholar
• Wang X, Yang S, Li S, Zhao L, Hao Y, Qin J, Zhang L, Zhang C, Bian W, Zuo L, et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut. 2020;69(12):2131–2142. doi:10.1136/gutjnl-2019-319766.
   PubMed Web of Science ®Google Scholar
• Xu KY, Xia GH, Lu JQ, Chen MX, Zhen X, Wang S, You C, Nie J, Zhou H-W, Yin J, et al. Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep. 2017;7(1):1445. doi:10.1038/s41598-017-01387-y.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, Hazen SL. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res. 2015;116(3):448–455. doi:10.1161/CIRCRESAHA.116.305360.
   PubMed Web of Science ®Google Scholar
• Gonzalez A, Krieg R, Massey HD, Carl D, Ghosh S, Gehr T, Ghosh SS. Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression. Nephrol Dial Transplant. 2019;34(5):783–794. doi:10.1093/ndt/gfy238.
   PubMed Web of Science ®Google Scholar
• Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, Lucia S, Adorini L, D’Agati VD, Levi J, et al. G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J Am Soc Nephrol. 2016;27(5):1362–1378. doi:10.1681/ASN.2014121271.
   PubMed Web of Science ®Google Scholar
• Kim KA, Jeong JJ, Yoo SY, Kim DH. Gut microbiota lipopolysaccharide accelerates inflamm-aging in mice. BMC Microbiol. 2016;16(1):9. doi:10.1186/s12866-016-0625-7.
   PubMedGoogle Scholar
• Xu Y, Liu X, Liu X, Chen D, Wang M, Jiang X, Xiong Z. The roles of the gut microbiota and chronic low-grade inflammation in older adults with frailty. Front Cell Infect Microbiol. 2021;11:675414. doi:10.3389/fcimb.2021.675414.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Shimokawa T, Yi H, Isobe K, Kojima T, Loskutoff DJ, Saito H. Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol. 2002;161(5):1805–1814. doi:10.1016/S0002-9440(10)64457-4.
   PubMed Web of Science ®Google Scholar
• Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000;71(10):1554–1560. doi:10.1902/jop.2000.71.10.1554.
   PubMed Web of Science ®Google Scholar
• Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017;8(1):845. doi:10.1038/s41467-017-00900-1.
   PubMed Web of Science ®Google Scholar
• Cho SO, Lim JW, Kim KH, Kim H. Diphenyleneiodonium inhibits the activation of mitogen-activated protein kinases and the expression of monocyte chemoattractant protein-1 in Helicobacter pylori-infected gastric epithelial AGS cells. Inflamm Res. 2011;60(5):501–507. doi:10.1007/s00011-010-0297-y.
   PubMed Web of Science ®Google Scholar
• Chu SH, Kim H, Seo JY, Lim JW, Mukaida N, Kim KH. Role of NF-kappaB and AP-1 on Helicobater pylori-induced IL-8 expression in AGS cells. Dig Dis Sci. 2003;48(2):257–265. doi:10.1023/A:1021963007225.
   PubMed Web of Science ®Google Scholar
• Brunt VE, Gioscia-Ryan RA, Richey JJ, Zigler MC, Cuevas LM, Gonzalez A, Vázquez‐Baeza Y, Battson ML, Smithson AT, Gilley AD, et al. Suppression of the gut microbiome ameliorates age-related arterial dysfunction and oxidative stress in mice. J Physiol. 2019;597(9):2361–2378. doi:10.1113/JP277336.
   PubMed Web of Science ®Google Scholar
• Hakhamaneshi MS, Abdolahi A, Vahabzadeh Z, Abdi M, Andalibi P. Toll-like receptor 4: a macrophage cell surface receptor is activated by trimethylamine-N-Oxide. Cell J. 2021;23(5):516–522. doi:10.22074/cellj.2021.7849.
   PubMed Web of Science ®Google Scholar
• Chen ML, Zhu XH, Ran L, Lang HD, Yi L, Mi MT. Trimethylamine-N-Oxide induces vascular inflammation by activating the NLRP3 inflammasome through the SIRT3-SOD2-mtROS signaling pathway. J Am Heart Assoc. 2017;6(9):e006347. doi:10.1161/JAHA.117.006347.
   PubMed Web of Science ®Google Scholar
• Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M. Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms. Front Cardiovasc Med. 2021;8:707529. doi:10.3389/fcvm.2021.707529.
   PubMed Web of Science ®Google Scholar
• Poznyak AV, Nikiforov NG, Starodubova AV, Popkova TV, Orekhov AN. Macrophages and foam cells: brief Overview of their role, linkage, and targeting potential in atherosclerosis. Biomedicines. 2021;9(9):1221. doi:10.3390/biomedicines9091221.
   PubMed Web of Science ®Google Scholar
• Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley M, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163(7):1585–1595. doi:10.1016/j.cell.2015.11.055.
   PubMed Web of Science ®Google Scholar
• Roberts AB, Gu X, Buffa JA, Hurd AG, Wang Z, Zhu W, Gupta N, Skye SM, Cody DB, Levison BS, et al. Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential. Nat Med. 2018;24(9):1407–1417. doi:10.1038/s41591-018-0128-1.
   PubMed Web of Science ®Google Scholar
• Lau K, Srivatsav V, Rizwan A, Nashed A, Liu R, Shen R, Akhtar M. Bridging the Gap between gut microbial dysbiosis and cardiovascular diseases. Nutrients. 2017;9(8):859. doi:10.3390/nu9080859.
   PubMed Web of Science ®Google Scholar
• Kwun JS, Kang SH, Lee HJ, Park HK, Lee WJ, Yoon CH, Suh J-W, Cho Y-S, Youn T-J, Chae I-H, et al. Comparison of thrombus, gut, and oral microbiomes in Korean patients with ST-elevation myocardial infarction: a case–control study. Experimental & Molecular Medicine. 2020;52(12):2069–2079. doi:10.1038/s12276-020-00543-1.
   PubMed Web of Science ®Google Scholar
• Brandsma E, Kloosterhuis NJ, Koster M, Dekker DC, Gijbels M, van der Velden S, Ríos-Morales M, van Faassen MJR, Loreti MG, de Bruin A, et al. A proinflammatory gut microbiota increases systemic inflammation and accelerates atherosclerosis. Circ Res. 2019;124(1):94–100. doi:10.1161/CIRCRESAHA.118.313234.
   PubMed Web of Science ®Google Scholar
• Bartolomaeus H, Balogh A, Yakoub M, Homann S, Marko L, Hoges S, Tsvetkov D, Krannich A, Wundersitz S, Avery EG, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage. Circulation. 2019;139(11):1407–1421. doi:10.1161/CIRCULATIONAHA.118.036652.
   PubMed Web of Science ®Google Scholar
• Yi C, Sun W, Ding L, Yan M, Sun C, Qiu C, Wang D, Wu L. Short-chain fatty acids Weaken ox-LDL-Induced cell inflammatory injury by inhibiting the NLRP3/Caspase-1 pathway and affecting cellular metabolism in THP-1 cells. Molecules. 2022;27(24):8801. doi:10.3390/molecules27248801.
   PubMed Web of Science ®Google Scholar
• Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur Heart J. 2022;43(6):518–533. doi:10.1093/eurheartj/ehab644.
   PubMed Web of Science ®Google Scholar
• Qiao CM, Sun MF, Jia XB, Shi Y, Zhang BP, Zhou ZL, Zhao L-P, Cui C, Shen Y-Q. Sodium butyrate causes α-synuclein degradation by an Atg5-dependent and PI3K/Akt/mTOR-related autophagy pathway. Exp Cell Res. 2020;387(1):111772. doi:10.1016/j.yexcr.2019.111772.
   PubMed Web of Science ®Google Scholar
• Bennett BJ, de Aguiar VT, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013;17(1):49–60. doi:10.1016/j.cmet.2012.12.011.
   PubMed Web of Science ®Google Scholar
• Guan B, Tong J, Hao H, Yang Z, Chen K, Xu H, Wang A. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. Acta Pharm Sin B. 2022;12(5):2129–2149. doi:10.1016/j.apsb.2021.12.011.
   PubMed Web of Science ®Google Scholar
• Ding L, Chang M, Guo Y, Zhang L, Xue C, Yanagita T, Zhang T, Wang Y. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism. Lipids Health Dis. 2018;17(1):286. doi:10.1186/s12944-018-0939-6.
   PubMed Web of Science ®Google Scholar
• Wang Z, You L, Ren Y, Zhu X, Mao X, Liang X, Wang T, Guo Y, Liu T, Xue J, et al. Finasteride alleviates high fat associated protein-overload nephropathy by inhibiting trimethylamine N-Oxide synthesis and regulating gut microbiota. Front Physiol. 2022;13:900961. doi:10.3389/fphys.2022.900961.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Z, Liu D, Jiang H, Cai C, Li G, Yu G. Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease. Front Pharmacol. 2022;13:839640. doi:10.3389/fphar.2022.839640.
   PubMed Web of Science ®Google Scholar
• Nakano T, Katsuki S, Chen M, Decano JL, Halu A, Lee LH, Pestana DVS, Kum AST, Kuromoto RK, Golden WS, et al. Uremic toxin indoxyl sulfate promotes proinflammatory macrophage activation via the interplay of OATP2B1 and Dll4-notch signaling. Circulation. 2019;139(1):78–96. doi:10.1161/CIRCULATIONAHA.118.034588.
   PubMed Web of Science ®Google Scholar
• Xue H, Chen X, Yu C, Deng Y, Zhang Y, Chen S, Chen X, Chen K, Yang Y, Ling W, et al. Gut Microbially produced indole-3-propionic acid inhibits atherosclerosis by promoting reverse cholesterol Transport and its deficiency is causally related to atherosclerotic cardiovascular disease. Circ Res. 2022;131(5):404–420. doi:10.1161/CIRCRESAHA.122.321253.
   PubMed Web of Science ®Google Scholar
• Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y, et al. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell. 2020;180(5):862–877.e22. doi:10.1016/j.cell.2020.02.016.
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Fu Y, Li J, Wang H, Xu L, Yang X. Dysbiosis of gut microbiota and metabolite phenylacetylglutamine in coronary artery disease patients with stent stenosis. Front Cardiovasc Med. 2022;9:832092. doi:10.3389/fcvm.2022.832092.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhao J, Wang Y, Bai M, Sun S. Specific alterations of gut microbiota in Chinese patients with hypertension: a systematic review and meta-analysis. Kidney Blood Press Res. 2022;47(7):433–447. doi:10.1159/000524282.
   PubMed Web of Science ®Google Scholar
• Wang X, Chen Z, Geng B, Cai J, D Elia L. The Bidirectional signal Communication of microbiota-gut-brain axis in hypertension. Int J Hypertens. 2021;2021:1–9. doi:10.1155/2021/8174789.
   Web of Science ®Google Scholar
• Richards EM, Li J, Stevens BR, Pepine CJ, Raizada MK. Gut Microbiome and Neuroinflammation in Hypertension. Circ Res. 2022;130(3):401–417. doi:10.1161/CIRCRESAHA.121.319816.
   PubMed Web of Science ®Google Scholar
• Liu G, Cheng J, Zhang T, Shao Y, Chen X, Han L, Zhou R, Wu B. Inhibition of microbiota-dependent trimethylamine N-Oxide production ameliorates high salt diet-induced sympathetic excitation and hypertension in rats by attenuating central neuroinflammation and oxidative stress. Front Pharmacol. 2022;13:856914. doi:10.3389/fphar.2022.856914.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang D, Li B, Li X, Lai X, Lei S, Li N, Zhang X. Relationship between plasma trimethylamine N-Oxide levels and renal dysfunction in patients with hypertension. Kidney Blood Press Res. 2021;46(4):421–432. doi:10.1159/000513033.
   PubMed Web of Science ®Google Scholar
• Chaves LD, McSkimming DI, Bryniarski MA, Honan AM, Abyad S, Thomas SA, Wells S, Buck M, Sun Y, Genco RJ, et al. Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis. Am J Physiol Renal Physiol. 2018;315(3):F487–F502. doi:10.1152/ajprenal.00092.2018.
   PubMed Web of Science ®Google Scholar
• Pluznick JL, Protzko RJ, Gevorgyan H, Peterlin Z, Sipos A, Han J, Brunet I, Wan L-X, Rey F, Wang T, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A. 2013;110(11):4410–4415. doi:10.1073/pnas.1215927110.
   PubMed Web of Science ®Google Scholar
• Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Sci Rep. 2016;6(1):37589. doi:10.1038/srep37589.
   PubMedGoogle Scholar
• Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171(24):5589–5602. doi:10.1111/bph.12876.
   PubMed Web of Science ®Google Scholar
• Yu Y, Wei SG, Weiss RM, Felder RB. Angiotensin II Type 1a Receptors in the Subfornical Organ Modulate Neuroinflammation in the Hypothalamic Paraventricular Nucleus in Heart Failure Rats. Neuroscience. 2018;381:46–58. doi:10.1016/j.neuroscience.2018.04.012.
   PubMed Web of Science ®Google Scholar
• Roshanravan N, Mahdavi R, Alizadeh E, Ghavami A, Rahbar SY, Mesri AN, Alipour S, Dastouri MR, Ostadrahimi A. The effects of sodium butyrate and inulin supplementation on angiotensin signaling pathway via promotion of akkermansia muciniphila abundance in type 2 diabetes; a randomized, double-blind, placebo-controlled trial. J Cardiovasc Thorac Res. 2017;9(4):183–190. doi:10.15171/jcvtr.2017.32.
   PubMed Web of Science ®Google Scholar
• Sharma RK, Yang T, Oliveira AC, Lobaton GO, Aquino V, Kim S, Richards EM, Pepine CJ, Sumners C, Raizada MK, et al. Microglial cells impact gut microbiota and gut pathology in angiotensin II-Induced hypertension. Circ Res. 2019;124(5):727–736. doi:10.1161/CIRCRESAHA.118.313882.
   PubMed Web of Science ®Google Scholar
• Khan I, Khan I, Kakakhel MA, Xiaowei Z, Ting M, Ali I, Fei Y, Jianye Z, Zhiqiang L, Lizhe A, et al. Comparison of microbial populations in the blood of patients with myocardial infarction and healthy individuals. Front Microbiol. 2022;13:845038. doi:10.3389/fmicb.2022.845038.
   PubMed Web of Science ®Google Scholar
• Zhou X, Li J, Guo J, Geng B, Ji W, Zhao Q, Li J, Liu X, Liu J, Guo Z, et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 2018;6(1):66. doi:10.1186/s40168-018-0441-4.
   PubMedGoogle Scholar
• Sandek A, Bjarnason I, Volk HD, Crane R, Meddings JB, Niebauer J, Kalra PR, Buhner S, Herrmann R, Springer J, et al. Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int J Cardiol. 2012;157(1):80–85. doi:10.1016/j.ijcard.2010.12.016.
   PubMed Web of Science ®Google Scholar
• Sandek A, Swidsinski A, Schroedl W, Watson A, Valentova M, Herrmann R, Scherbakov N, Cramer L, Rauchhaus M, Grosse-Herrenthey A, et al. Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol. 2014;64(11):1092–1102. doi:10.1016/j.jacc.2014.06.1179.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Bobryshev YV, Kozarov E, Sobenin IA, Orekhov AN. Role of gut microbiota in the modulation of atherosclerosis-associated immune response. Front Microbiol. 2015;6:671. doi:10.3389/fmicb.2015.00671.
   PubMed Web of Science ®Google Scholar
• Gallo A, Macerola N, Favuzzi AM, Nicolazzi MA, Gasbarrini A, Montalto M. The gut in heart failure: Current knowledge and novel frontiers. Med Princ Pract. 2022;31(3):203–214. doi:10.1159/000522284.
   PubMed Web of Science ®Google Scholar
• Tang T, Chen HC, Chen CY, Yen C, Lin CJ, Prajnamitra RP, Chen L-L, Ruan S-C, Lin J-H, Lin P-J, et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation. 2019;139(5):647–659. doi:10.1161/CIRCULATIONAHA.118.035235.
   PubMed Web of Science ®Google Scholar
• Mayerhofer C, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Trøseid M, et al. Increased secondary/primary bile acid ratio in chronic heart failure. J Card Fail. 2017;23(9):666–671. doi:10.1016/j.cardfail.2017.06.007.
   PubMed Web of Science ®Google Scholar
• Zhang R, Ma WQ, Fu MJ, Li J, Hu CH, Chen Y, Zhou M-M, Gao Z-J, He Y-L. Overview of bile acid signaling in the cardiovascular system. World J Clin Cases. 2021;9(2):308–320. doi:10.12998/wjcc.v9.i2.308.
   PubMed Web of Science ®Google Scholar
• Zong X, Fan Q, Yang Q, Pan R, Zhuang L, Tao R. Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure. ESC Heart Fail. 2022;9(4):2645–2653. doi:10.1002/ehf2.13989.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Cai B, Sun Y, Deng H, Wang H, Qiao Z. Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure. Front Cardiovasc Med. 2022;9:1076806. doi:10.3389/fcvm.2022.1076806.
   PubMed Web of Science ®Google Scholar
• Molinaro A, Nemet I, Bel LP, Chakaroun R, Nielsen T, Aron-Wisnewsky J, Bergh P-O, Li L, Henricsson M, Køber L, et al. Microbially produced imidazole propionate is associated with heart failure and mortality. JACC Heart Fail. 2023;11(7):810–821. doi:10.1016/j.jchf.2023.03.008.
   PubMed Web of Science ®Google Scholar
• Koh A, Molinaro A, Stahlman M, Khan MT, Schmidt C, Manneras-Holm L, Wu H, Carreras A, Jeong H, Olofsson LE, et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell. 2018;175(4):947–961.e17. doi:10.1016/j.cell.2018.09.055.
   PubMed Web of Science ®Google Scholar
• Hu Y, Pan Z, Huang Z, Li Y, Han N, Zhuang X, Peng H, Gao Q, Wang Q, Yang Lee BJ, et al. Gut microbiome-targeted modulations regulate metabolic profiles and alleviate altitude-related cardiac hypertrophy in rats. Microbiol Spectr. 2022;10(1):e105321. doi:10.1128/spectrum.01053-21.
   Web of Science ®Google Scholar
• Asgharzadeh F, Bargi R, Beheshti F, Hosseini M, Farzadnia M, Khazaei M. Thymoquinone prevents myocardial and perivascular fibrosis induced by chronic lipopolysaccharide exposure in male rats: - thymoquinone and cardiac fibrosis. J Pharmacopuncture. 2018;21(4):284–293. doi:10.3831/KPI.2018.21.032.
   PubMed Web of Science ®Google Scholar
• Singh MV, Swaminathan PD, Luczak ED, Kutschke W, Weiss RM, Anderson ME. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol. 2012;52(5):1135–1144. doi:10.1016/j.yjmcc.2012.01.021.
   PubMed Web of Science ®Google Scholar
• Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, Polhemus DJ, Tang WHW, Wu Y, Hazen SL, et al. Choline diet and its gut microbe–derived metabolite, trimethylamine N-Oxide, exacerbate pressure overload–induced heart failure. Circ Heart Fail. 2016;9(1):e2314. doi:10.1161/CIRCHEARTFAILURE.115.002314.
   PubMed Web of Science ®Google Scholar
• Li X, Geng J, Zhao J, Ni Q, Zhao C, Zheng Y, Chen X, Wang L. Trimethylamine N-Oxide exacerbates cardiac fibrosis via activating the NLRP3 inflammasome. Front Physiol. 2019;10:866. doi:10.3389/fphys.2019.00866.
   PubMed Web of Science ®Google Scholar
• Zou D, Li Y, Sun G. Attenuation of circulating trimethylamine N-Oxide prevents the progression of cardiac and renal dysfunction in a rat model of chronic cardiorenal syndrome. Front Pharmacol. 2021;12:751380. doi:10.3389/fphar.2021.751380.
   PubMed Web of Science ®Google Scholar
• Organ CL, Li Z, Sharp TR, Polhemus DJ, Gupta N, Goodchild TT, Tang WHW, Hazen SL, Lefer DJ. Nonlethal inhibition of gut microbial trimethylamine N-oxide production improves cardiac function and remodeling in a murine model of heart failure. J Am Heart Assoc. 2020;9(10):e16223. doi:10.1161/JAHA.119.016223.
   Web of Science ®Google Scholar
• Singh SP, Chand HS, Banerjee S, Agarwal H, Raizada V, Roy S, Sopori M. Acetylcholinesterase inhibitor pyridostigmine bromide attenuates gut pathology and bacterial dysbiosis in a murine model of ulcerative colitis. Dig Dis Sci. 2020;65(1):141–149. doi:10.1007/s10620-019-05838-6.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhao M, He X, Wu Q, Li DL, Zang WJ. Pyridostigmine Protects Against diabetic cardiomyopathy by regulating vagal activity, gut microbiota, and branched-chain amino acid catabolism in diabetic mice. Front Pharmacol. 2021;12:647481. doi:10.3389/fphar.2021.647481.
   PubMed Web of Science ®Google Scholar
• Gawalko M, Agbaedeng TA, Saljic A, Muller DN, Wilck N, Schnabel R, Penders J, Rienstra M, van Gelder I, Jespersen T, et al. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. Cardiovasc Res. 2022;118(11):2415–2427. doi:10.1093/cvr/cvab292.
   PubMed Web of Science ®Google Scholar
• Zuo K, Li J, Li K, Hu C, Gao Y, Chen M, Hu R, Liu Y, Chi H, Wang H, et al. Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. Gigascience. 2019;8(6):giz058. doi:10.1093/gigascience/giz058.
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Zhang W, Zhong J, Li J, Xu L, Yang X. Association between gut microbiota dysbiosis and the CHA2DS2-VASc score in atrial fibrillation patients. Int J Clin Pract. 2022;2022:1–10. doi:10.1155/2022/7942605.
   Web of Science ®Google Scholar
• Scott LJ, Li N, Dobrev D. Role of inflammatory signaling in atrial fibrillation. Int J Cardiol. 2019;287:195–200. doi:10.1016/j.ijcard.2018.10.020.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zuo K, Fang C, Yin X, Liu X, Zhong J, Li K, Li J, Xu L, Yang X, et al. Altered synthesis of genes associated with short-chain fatty acids in the gut of patients with atrial fibrillation. Bmc Genom. 2021;22(1):634. doi:10.1186/s12864-021-07944-0.
   PubMed Web of Science ®Google Scholar
• Zuo K, Fang C, Liu Z, Fu Y, Liu Y, Liu L, Wang Y, Yin X, Liu X, Li J, et al. Commensal microbe-derived SCFA alleviates atrial fibrillation via GPR43/NLRP3 signaling. Int J Biol Sci. 2022;18(10):4219–4232. doi:10.7150/ijbs.70644.
   PubMed Web of Science ®Google Scholar
• Yang WT, Yang R, Zhao Q, Li XD, Wang YT. A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation. Ann Palliat Med. 2021;10(11):11512–11523. doi:10.21037/apm-21-2763.
   PubMed Web of Science ®Google Scholar
• Linz D, Gawalko M, Sanders P, Penders J, Li N, Nattel S, Dobrev D. Does gut microbiota affect atrial rhythm? Causalities and speculations. Eur Heart J. 2021;42(35):3521–3525. doi:10.1093/eurheartj/ehab467.
   PubMed Web of Science ®Google Scholar
• Meng G, Zhou X, Wang M, Zhou L, Wang Z, Wang M, Deng J, Wang Y, Zhou Z, Zhang Y, et al. Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways. EBioMedicine. 2019;44:656–664. doi:10.1016/j.ebiom.2019.03.066.
   PubMed Web of Science ®Google Scholar
• Chen YY, Sun ZW, Jiang JP, Kang XD, Wang LL, Shen YL, Xie X-D, Zheng L-R. α-adrenoceptor-mediated enhanced inducibility of atrial fibrillation in a canine system inflammation model. Mol Med Rep. 2017;15(6):3767–3774. doi:10.3892/mmr.2017.6477.
   PubMed Web of Science ®Google Scholar
• Fang C, Zuo K, Jiao K, Zhu X, Fu Y, Zhong J, Xu L, Yang X. Pagln, an atrial fibrillation-Linked gut microbial metabolite, acts as a promoter of atrial myocyte injury. Biomolecules. 2022;12(8):1120. doi:10.3390/biom12081120.
   PubMed Web of Science ®Google Scholar
• Yuan S, Cai Z, Luan X, Wang H, Zhong Y, Deng L, Feng J. Gut microbiota: a new therapeutic target for diabetic cardiomyopathy. Front Pharmacol. 2022;13:963672. doi:10.3389/fphar.2022.963672.
   PubMed Web of Science ®Google Scholar
• Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, Young VB. Recovery of the gut microbiome following fecal microbiota transplantation. Mbio. 2014;5(3):e814–e893. doi:10.1128/mBio.00893-14.
   Web of Science ®Google Scholar
• Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, Dallinga–Thie GM, Ackermans MT, Serlie MJ, Oozeer R, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913–916.e7. doi:10.1053/j.gastro.2012.06.031.
   PubMed Web of Science ®Google Scholar
• Manrique P, Zhu Y, van der Oost J, Herrema H, Nieuwdorp M, de Vos WM, Young M. Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome. Gut Microbes. 2021;13(1):1–15. doi:10.1080/19490976.2021.1897217.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Jiang C, Xie C, Patterson AD. Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease. Dig Dis. 2017;35(3):178–184. doi:10.1159/000450908.
   PubMed Web of Science ®Google Scholar
• Xu S, Jia P, Fang Y, Jin J, Sun Z, Zhou W, Li J, Zhang Y, Wang X, Ren T, et al. Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation. Kidney Int. 2022;101(5):987–1002. doi:10.1016/j.kint.2022.01.029.
   PubMed Web of Science ®Google Scholar